Limin Ma

Jan 31, 2024 | arxiv.org | Limin Ma

Jan 30, 2024 | arxiv.org | Limin Ma

arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website. Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them. Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.

Dec 30, 2023 | dovepress.com | Xiaosong Zhang |Limin Ma

Back to Journals » Cancer Management and Research » Volume 16 Authors Zhang X, Ma L Received 30 December 2023 Accepted for publication 27 May 2024 Published 31 May 2024 Volume 2024:16 Pages 537—546 DOI https://doi.org/10.2147/CMAR.S457269 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Chien-Feng Li Xiaosong Zhang,1,2 Limin Ma1 1Department of Urology, Affiliated Hospital of Nantong University, Medical School of...

Jun 11, 2023 | onlinelibrary.wiley.com | Limin Ma |Qingyuan Wu |Jinxian Yuan |You Wang

4 DISCUSSION This is, to our knowledge, the first study that describes the impact of ANXA2 on epilepsy. It was found that ANXA2 could regulate excitatory synaptic activity mediated by the GluA1 subunit of AMPAR, thus exacerbating seizure activity. First, elevated ANXA2 protein expression was detected in TLE patients and epilepsy models in vivo and in vitro.